2021 End of Year Trading Update

RNS Number : 2584Y
Science Group PLC
13 January 2022
 

 

 

 

 

13 January 2022

 

Science Group plc

 

 

2021 End-of Year Trading Update

 

 

The momentum reported during 2021, which resulted in multiple profit forecast upgrades during the year, continued through the final months. As a result, 2021 will be another record for Science Group with revenue in excess of £80 million and adjusted operating profit anticipated to be in the order of £16 million, an increase of over 45% on the prior year (£10.9 million) and more than double that reported in 2019, the year before the pandemic outbreak.

 

This outstanding performance, delivering a very strong operating margin, has been achieved in a challenging environment due to the ongoing Covid pandemic and global supply chain constraints. All the divisions have contributed to this success, with the Group overall benefitting from the operational efficiencies resulting from the greater scale following the 2019 Frontier acquisition.

 

The past year has seen significant corporate activity, including the acquisition of a strategic shareholding in TP Group, a royalty buy-out and the acquisition of Magic Systech. Even so, due to the excellent operating cash conversion, enhanced by the Group's first equity fund raising in over a decade, at 31 December 2021 the Group had gross cash of £34.3 million and net funds of £19.0 million. In addition, Science Group signed a new £25 million revolving credit facility with its bank in December. The Group's robust balance sheet and undrawn facilities, enable the Board to continue to explore further corporate development opportunities in the year ahead.

 

Reflecting this resilient performance and significant earnings growth, the Board anticipate recommending a 25% increase, to 5 pence per share, in the dividend payment to Science Group shareholders at the next Annual General Meeting. In parallel, the Group's profit share and bonus schemes will be sharing the success with the employees and management whose commitment and dedication throughout the two years of the pandemic have continued to deliver value to Science Group shareholders.

 

End

 

Science Group plc

 

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

 

 

 

 

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

 

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

 

 

Liberum Capital Limited (Joint Broker)

 

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

 

 

 

 

 

 

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014).  The person responsible for this announcement is Martyn Ratcliffe, Chairman .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUWGGUPPGAP
UK 100

Latest directors dealings